{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:43:31Z","timestamp":1776120211041,"version":"3.50.1"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.12788\/jfp.0521","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T15:30:09Z","timestamp":1672759809000},"source":"Crossref","is-referenced-by-count":1,"title":["How does gender-affirming hormone therapy affect QOL in transgender patients?"],"prefix":"10.12788","volume":"71","author":[{"given":"Sarah","family":"Wilhelm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","container-title":["The Journal of Family Practice"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/JFP07112442.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T15:30:10Z","timestamp":1672759810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/familymedicine\/article\/260062\/mental-health\/how-does-gender-affirming-hormone-therapy-affect-qol"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"URL":"https:\/\/doi.org\/10.12788\/jfp.0521","relation":{},"subject":[],"published":{"date-parts":[[2022,12]]}}}